0001415889-24-012020.txt : 20240502
0001415889-24-012020.hdr.sgml : 20240502
20240502170912
ACCESSION NUMBER: 0001415889-24-012020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240430
FILED AS OF DATE: 20240502
DATE AS OF CHANGE: 20240502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harmon Cyrus
CENTRAL INDEX KEY: 0001831410
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 24909627
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
form4-05022024_090504.xml
X0508
4
2024-04-30
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831410
Harmon Cyrus
C/O OLEMA PHARMACEUTICALS, INC.
780 BRANNAN ST
SAN FRANCISCO
CA
94103
true
false
false
false
1
Common Stock
2024-04-30
4
S
0
15000
9.51
D
811283
D
Common Stock
122028
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated May 16, 2023.
The weighted average sale price for the transaction reported was $9.51, and the range of prices was between $9.20 and $9.91. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.
/s/ Shane Kovacs, Attorney-in-Fact
2024-05-02